Diagnostic assessment of first-episode psychosis patients and adherence to German S3 guidelines: a retrospective cross-sectional study [0.03%]
首次精神病发作患者的诊断评估及德国S3指南的依从性：一项回顾性横断面研究
Karen J Schulz,Marie C Khorsandian,Claudio Corda et al.
Karen J Schulz et al.
BACKGROUND: Guidelines for diagnostic work-up in first-episode psychosis (FEP) vary worldwide. The German DGPPN S3 guidelines recommend a comprehensive work-up, including neuroimaging. However, real-world adherence to these recommendations ...
Endocrine care of transgender and gender-diverse adults: Swiss recommendations [0.03%]
瑞士关于性别多样成人内分泌护理的建议
Hüseyin Cihan,Barbara Bischofberger-Baumann,Julie Bucher et al.
Hüseyin Cihan et al.
Transgender and gender-diverse individuals require standardised, evidence-based and culturally sensitive endocrine care. International guidelines such as those from the World Professional Association for Transgender Health (WPATH) and the E...
Practice Guideline
Swiss medical weekly. 2026 Jan 26:156:5059. DOI:10.57187/5059 2026
Brain lesions and cognitive decline in patients with atrial fibrillation: a prospective multicentre cohort study [0.03%]
房颤患者脑部病变与认知功能下降的相关性：前瞻性多中心队列研究
Katalin Bhend,Rebecca Paladini,Stefanie Aeschbacher et al.
Katalin Bhend et al.
Study aim: Atrial fibrillation (AF) is associated with a high burden of vascular brain lesions, most of which are covert. We aimed to assess the association between vascular brain lesions (brain infarcts, microbleeds, whi...
Multicenter Study
Swiss medical weekly. 2026 Jan 9:156:4059. DOI:10.57187/s.4059 2026
Trends over time and risk factors in inappropriate prescribing in older adults with multimorbidity and polypharmacy: a longitudinal secondary analysis of the OPERAM trial [0.03%]
多病共存和用药复杂老年人不适当处方的长期变化趋势及其风险因素：来自药物管理优化治疗老年多重疾病患者（OPERAM）试验的事后分析
Jonathan Huschka,Katharina Tabea Jungo,Valerie Aponte Ribero et al.
Jonathan Huschka et al.
BACKGROUND AND AIM OF THE STUDY: Polypharmacy is common among older adults and associated with potentially inappropriate medications and potential prescribing omissions, which together constitute potentially inappropriate prescriptions, con...
Randomized Controlled Trial
Swiss medical weekly. 2026 Feb 12:156:4892. DOI:10.57187/4892 2026
Efficacy and safety outcomes from the MATISSE phase 3 trial of maternal bivalent RSVpreF vaccination among pregnant women vaccinated at 32 to 36 weeks of gestation [0.03%]
母孕期（妊娠32至36周）接种双价RSV融合前疫苗的Ⅲ期MATISSE试验有效性和安全性结果分析
Emma Shittu,Barbara A Pahud,David Radley et al.
Emma Shittu et al.
Aims of the study: Marketing authorisation of the bivalent respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) for maternal vaccination was predominantly based on safety and efficacy findings from the ...
Clinical Trial
Swiss medical weekly. 2026 Jan 31:156:4711. DOI:10.57187/4711 2026
"Aare You Safe?" River-related presentations and clinical outcomes at a Swiss tertiary emergency department: a retrospective cross-sectional study [0.03%]
“你安全吗？”，瑞士三级急诊室的河流相关就诊情况及临床结果：一项回顾性横截面研究
Julius Husarek,Thomas Maurer,Tany Zuerrer et al.
Julius Husarek et al.
BACKGROUND: Urban swimming, especially in the Aare River, is popular in Switzerland but carries risks, particularly for those unfamiliar with its currents and hazards. This study describes the epidemiology of river-related emergency departm...
Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysis [0.03%]
布路西特用于瑞士早期使用计划中慢性D型肝炎患者的效果和安全性：一项回顾性分析
Mirjam Kolev,Salomé Wolf,Elizabeth Petràš et al.
Mirjam Kolev et al.
BACKGROUND AND AIMS: Bulevirtide 2 mg/day was approved in Switzerland in February 2025 for the treatment of chronic hepatitis D virus (HDV) infection. We present real-world data on efficacy and safety in patients treated under an early acce...
Multicenter Study
Swiss medical weekly. 2026 Feb 23:156:4736. DOI:10.57187/4736 2026
Bilirubin interference in creatinine assays: cross-sectional analysis of the impact on the MELD score and CKD staging using Jaffe vs enzymatic methods [0.03%]
胆红素对肌酐检测的干扰：假酶法与酶法对MELD评分和CKD分期影响的横断面分析研究
Kathrin Frey,Joanna Gawinecka,Arnold Von Eckardstein et al.
Kathrin Frey et al.
Background: Reliable and accurate measurement of creatinine is essential for the estimation of kidney function (eGFR) and for survival prediction with the model of the end-stage liver disease (MELD) score. Bilirubin inter...
Comparative Study
Swiss medical weekly. 2026 Feb 25:156:4707. DOI:10.57187/4707 2026
A qualitative assessment of the use of artificial intelligence in public sector health organisations in Ontario, Canada [0.03%]
加拿大安大略省公共部门卫生组织中人工智能应用的定性评估
Steven Habbous,Jeremy Herring,Tina Badiani et al.
Steven Habbous et al.
Background: Advancements in artificial intelligence (AI) and machine learning (ML) capabilities and increased access to methods have enabled population-level analysis for research and health system monitoring. However, go...
Swiss caesarean section rates according to Robson's Ten-Group Classification System: an observational study [0.03%]
基于罗宾逊10分组分类系统的瑞士地区剖宫产率差异：一项观察性研究
Stephen Adjahou,Gian-Paolo Klinke,Alexandre Vallée et al.
Stephen Adjahou et al.
Study aims: Robson's Ten-Group Classification System (TGCS) was proposed to describe caesarean section rates by ten patient-centred risk-specific groups. The aim of the study was to describe Swiss caesarean section rates ...
Observational Study
Swiss medical weekly. 2026 Jan 31:156:4231. DOI:10.57187/4231 2026